tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Alethia Young, 239 are a BUY (79.4%), 57 are a HOLD (18.94%), 5 are a SELL (1.66%).
Analyst Alethia Young, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 55.12% that have a potential upside of 47.01% achieved within 311 days.
Alethia Young’s has documented 588 price targets and ratings displayed on 47 stocks. The coverage is on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on RCUS, Arcus Biosciences at 05-Jul-2024.
Analyst best performing recommendations are on ARVN (ARVINAS).
The best stock recommendation documented was for BIIB (BIOGEN) at 11/3/2020. The price target of $278 was fulfilled within 1 day with a profit of $30.99 (12.55%) receiving and performance score of 125.46.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$2
$1.82 (1011.11%)
$5
5 years 9 months 19 days ago
(03-May-2019)
2/3 (66.67%)
$-0.96 (-32.43%)
528
Hold
$4
7 years 14 days ago
(08-Feb-2018)
4/4 (100%)
$-0.81 (-16.84%)
106
Buy
$5
$4.82 (2677.78%)
$6
7 years 2 months 11 days ago
(11-Dec-2017)
0/4 (0%)
$2.14 (74.83%)
Buy
$10
7 years 5 months 10 days ago
(12-Sep-2017)
0/2 (0%)
$5.79 (137.53%)
Hold
$4
$3.82 (2122.22%)
$5
7 years 5 months 11 days ago
(11-Sep-2017)
6/7 (85.71%)
$0.17 (4.44%)
49
What Year was the first public recommendation made by Alethia Young?
